Repligen Corp (NASDAQ:RGEN)

29.08
Delayed Data
As of 12:53pm ET
 -1.28 / -4.23%
Today’s Change
12.60
Today|||52-Week Range
34.15
+46.84%
Year-to-Date

Today’s Trading

Previous close30.36
Today’s open30.24
Day’s range28.88 - 30.50
Volume335,463
Average volume (3 months)390,692
Market cap$995.1M
Dividend yield--
Data as of 12:53pm ET, 04/01/2015

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)+14.00%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-6.78%
P/E ratio118.4
Price/Sales10.13
Price/Book8.91

Competitors

 Today’s
change
Today’s
% change
OREXOrexigen Therapeutic...-0.22-2.81%
ARRYArray Biopharma Inc-0.16-2.17%
TXMDTherapeuticsMD Inc-0.05-0.83%
INSMInsmed Inc-0.04-0.19%
Data as of 1:09pm ET, 04/01/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)$0.07
Annual revenue (last year)$63.5M
Annual profit (last year)$8.2M
Net profit margin12.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Treasurer, Director &
CAO
Walter C. Herlihy
Chief Operating Officer &
Director
Tony J. Hunt
Corporate headquarters
Waltham, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account